Article Text

Download PDFPDF
Review: continuous positive airway pressure devices are effective and cost-effective for obstructive sleep apnoea

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


Are continuous positive airway pressure (CPAP) devices effective and cost-effective for treatment of obstructive sleep apnoea-hypopnoea syndrome (OSAHS)?

Review scope

Included studies compared CPAP devices (used for ⩾1 wk) with placebo, supportive or usual care, or dental devices in adults (⩾16 y of age) with OSAHS. Studies in patients with central nervous system dysfunction or heart failure were excluded. Outcomes included subjective daytime sleepiness (Epworth Sleepiness Scale, ESS), ability to stay awake (Maintenance of Wakefulness Test, MWT), blood pressure (BP), and cost-effectiveness.

Review methods

15 electronic databases including Medline, CINAHL, EMBASE/Excerpta Medica, and Cochrane Central Register of Controlled Trials (to Nov 2006); journals (2005 to May 2007); conference proceedings (2005–6); industry submissions; and the reference list of a previous Cochrane review on the topic were searched for randomised controlled trials (RCTs). 48 RCTs (n = 2521, mean age 44–58 y, 52–100% men) …

View Full Text


  • Source of funding: Health Technology Assessment Programme.